Seres Therapeutics, Inc. (MCRB) Q2 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Seres Therapeutics, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.000 -- 00:00:03.160 Please go ahead. 00:00:03.160 -- 00:00:08.040 Thank you and good morning. Our press release for the company's second quarter 2025 financial 00:00:08.040 -- 00:00:10.980 results and business updates became available at 7 a.m. 00:00:10.980 -- 00:00:15.340 Eastern time this morning and can be found on the Investors in Use section of the company's 00:00:15.340 -- 00:00:20.220 website. The company has also posted an updated corporate presentation to the website. 00:00:20.220 -- 00:00:24.040 I'd like to remind you that we're making forward-looking statements including statements 00:00:24.040 -- 00:00:28.880 about the timing and results of our clinical studies and data readouts, future product 00:00:28.880 -- 00:00:33.300 candidates, clinical development plans and commercial opportunities, 00:00:33.300 -- 00:00:38.620 communications with feedback from or submissions to the FDA, operating plans and 00:00:38.620 -- 00:00:43.780 our future cash runway, future obligations related to the vows sale, our ability to 00:00:43.780 -- 00:00:48.780 secure a business development deal, partnerships and or generate or obtain 00:00:48.780 -- 00:00:52.060 additional capital or financing, 00:00:52.060 -- 00:00:57.340 our planned strategic focus, anticipated timing of any of the foregoing and 00:00:57.340 -- 00:01:00.240 other statements which are not historical fact. 00:01:00.240 -- 00:01:04.600 Actual results may differ materially. Additionally, these statements are subject to certain 00:01:04.600 -- 00:01:09.000 risks and uncertainties which are discussed under the risk factor section of our recent 00:01:09.000 -- 00:01:13.940 SEC filings. Any forward-looking statements made on today's call represent our views 00:01:13.940 -- 00:01:19.260 as of today onl...